Works matching IS 08876924 AND DT 2005 AND VI 19 AND IP 1

Results: 37

A phase I study of 153Sm-EDTMP with fixed high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma.

Published in:

2005

By:

Dispenzieri, A;
Wiseman, G A;
Lacy, M Q;
Litzow, M R;
Anderson, P M;
Gastineau, D A;
Tefferi, A;
Inwards, D J;
Micallef, I N M;
Ansell, S M;
Porrata, L;
Elliott, M A;
Lust, J A;
Greipp, P R;
Rajkumar, S V;
Fonseca, R;
Witzig, T E;
Erlichman, C;
Sloan, J A;
Gertz, M A

Publication type:

journal article

Evidence for D276G and L364I Bcr-Abl mutations in Ph+leukaemic cells obtained from patients resistant to Imatinib.

Published in:

2005

By:

Piazza, R G;
Magistroni, V;
Gasser, M;
Andreoni, F;
Galietta, A;
Scapozza, L;
Gambacorti-Passerini, C

Publication type:

Letter

Raf and VEGF: emerging therapeutic targets in Kaposi's sarcoma-associated herpesvirus infection and angiogenesis in hematopoietic and nonhematopoietic tumors.

Published in:

Leukemia (08876924), 2005, v. 19, n. 1, p. 18, doi. 10.1038/sj.leu.2403532

By:

Hamden, K E;
Whitman, A G;
Ford, P W;
Shelton, J G;
McCubrey, J A;
Akula, S M

Publication type:

Article

Raji revisited: cytogenetics of the original Burkitt's lymphoma cell line.

Published in:

2005

By:

Karpova, M B;
Schoumans, J;
Ernberg, I;
Henter, J-I;
Nordenskjöld, M;
Fadeel, B

Publication type:

Letter

Translocation t(1;19) is related to low cellular drug resistance in childhood acute lymphoblastic leukaemia.

Published in:

2005

By:

Frost, B M;
Forestier, E;
Gustafsson, G;
Nygren, P;
Hellebostad, M;
Jonmundsson, G;
Kanerva, J;
Schmiegelow, K;
Larsson, R;
Lönnerholm, G

Publication type:

Letter

Efficacy of melphalan, arsenic trioxide, and ascorbic acid combination therapy (MAC) in relapsed and refractory multiple myeloma.

Published in:

2005

By:

Borad, M J;
Swift, R;
Berenson, J R

Publication type:

Letter

Multipotent neural precursors express neural and hematopoietic factors, and enhance ex vivo expansion of cord blood CD34+ cells, colony forming units and NOD/SCID-repopulating cells in contact and noncontact cultures.

Published in:

Leukemia (08876924), 2005, v. 19, n. 1, p. 91, doi. 10.1038/sj.leu.2403542

By:

Li, K;
Lee, S M;
Su, R J;
Zhang, X B;
Yuen, P M P;
Li, C K;
Yang, M;
Tsang, K S;
James, A E;
Tse, Y H J;
Ng, L Y W;
Fok, T F

Publication type:

Article

Translocation t(1;6)(p35.3;p25.2): a new recurrent aberration in‘unmutated’B-CLL.

Published in:

Leukemia (08876924), 2005, v. 19, n. 1, p. 77, doi. 10.1038/sj.leu.2403543

By:

Michaux, L;
Wlodarska, I;
Rack, K;
Stul, M;
Criel, A;
Maerevoet, M;
Marichal, S;
Demuynck, H;
Mineur, P;
Samani, K Kargar;
Hoof, A Van;
Ferrant, A;
Marynen, P;
Hagemeijer, A

Publication type:

Article

Is physical fitness decreased in survivors of childhood leukemia? A systematic review.

Published in:

Leukemia (08876924), 2005, v. 19, n. 1, p. 13, doi. 10.1038/sj.leu.2403547

By:

van Brussel, M;
Takken, T;
Lucia, A;
van der Net, J;
Helders, P J M

Publication type:

Article

KIAA1509 is a novel PDGFRB fusion partner in imatinib-responsive myeloproliferative disease associated with a t(5;14)(q33;q32).

Published in:

Leukemia (08876924), 2005, v. 19, n. 1, p. 27, doi. 10.1038/sj.leu.2403548

By:

Levine, R L;
Wadleigh, M;
Sternberg, D W;
Wlodarska, I;
Galinsky, I;
Stone, R M;
DeAngelo, D J;
Gary Gilliland, D;
Cools, J

Publication type:

Article

Anagrelide is effective in treating patients with hydroxyurea-resistant thrombocytosis in patients with chronic myeloid leukemia.

Published in:

2005

By:

Silver, R T

Publication type:

journal article

CD34+ marrow progenitors from MDS patients with high levels of intramedullary apoptosis have reduced expression ofa4ß1 anda5ß1 integrins.

Published in:

Leukemia (08876924), 2005, v. 19, n. 1, p. 57, doi. 10.1038/sj.leu.2403551

By:

Delforge, M;
Raets, V;
Van Duppen, V;
Vandenberghe, P;
Boogaerts, M

Publication type:

Article

Induction of gene expression by 5-Aza-2'-deoxycytidine in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) but not epithelial cells by DNA-methylation-dependent and -independent mechanisms.

Published in:

Leukemia (08876924), 2005, v. 19, n. 1, p. 103, doi. 10.1038/sj.leu.2403552

By:

Schmelz, K;
Sattler, N;
Wagner, M;
Lübbert, M;
Dörken, B;
Tamm, I

Publication type:

Article

Immunosurveillance of childhood ALL: polymorphic interferon-?alleles are associated with age at diagnosis and clinical risk groups.

Published in:

Leukemia (08876924), 2005, v. 19, n. 1, p. 44, doi. 10.1038/sj.leu.2403553

By:

Cloppenborg, T;
Stanulla, M;
Zimmermann, M;
Schrappe, M;
Welte, K;
Klein, C

Publication type:

Article

Overexpression of HOXB4 confers a myelo-erythroid differentiation delay in vitro.

Published in:

2005

By:

Milsom, M D;
Duxbury, R;
Gagen, D;
Humphries, R K;
Schmidt, M;
von-Kalle, C;
Fairbairn, L J

Publication type:

Letter

Phenotype and function of a CD56+peripheral blood monocyte.

Published in:

Leukemia (08876924), 2005, v. 19, n. 1, p. 69, doi. 10.1038/sj.leu.2403550

By:

Sconocchia, G;
Keyvanfar, K;
El Ouriaghli, F;
Grube, M;
Rezvani, K;
Fujiwara, H;
McCoy, J P;
Hensel, N;
Barrett, A J

Publication type:

Article

Development of a D-FISH method to detect DEK/CAN fusion resulting from t(6;9)(p23;q34) in patients with acute myelogenous leukemia.

Published in:

Leukemia (08876924), 2005, v. 19, n. 1, p. 126, doi. 10.1038/sj.leu.2403557

By:

Shearer, B M;
Knudson, R A;
Flynn, H C;
Ketterling, R P

Publication type:

Article

Impact of plasmacytoid dendritic cells on outcome after reduced-intensity conditioning allogeneic stem cell transplantation.

Published in:

Leukemia (08876924), 2005, v. 19, n. 1, p. 1, doi. 10.1038/sj.leu.2403558

By:

Mohty, M;
Blaise, D;
Faucher, C;
Bardou, V-J;
Gastaut, J-A;
Viens, P;
Olive, D;
Gaugler, B

Publication type:

Article

Drug-induced immunophenotypic modulation in childhood ALL: implications for minimal residual disease detection.

Published in:

Leukemia (08876924), 2005, v. 19, n. 1, p. 49, doi. 10.1038/sj.leu.2403559

By:

Gaipa, G;
Basso, G;
Maglia, O;
Leoni, V;
Faini, A;
Cazzaniga, G;
Bugarin, C;
Veltroni, M;
Michelotto, B;
Ratei, R;
Coliva, T;
Valsecchi, M G;
Biondi, A;
Dworzak, M N

Publication type:

Article

Inhibition of PI3K, mTOR and MEK signaling pathways promotes rapid apoptosis in B-lineage ALL in the presence of stromal cell support.

Published in:

Leukemia (08876924), 2005, v. 19, n. 1, p. 98, doi. 10.1038/sj.leu.2403560

By:

Bertrand, F E;
Spengemen, J D;
Shelton, J G;
McCubrey, J A

Publication type:

Article

Immune recovery after low-dose Campath therapy in a group of pretreated patients affected by B-cell chronic lymphocytic leukemia.

Published in:

2005

By:

Laurenti, L;
Piccioni, P;
Tarnani, M;
Chiusolo, P;
Piccirillo, N;
Rumi, C;
Sora, F;
Sica, S;
Leone, G

Publication type:

Letter

Rapid reconstitution of dendritic cells after allogeneic transplantation of CD133+ selected hematopoietic stem cells.

Published in:

2005

By:

Bornhäuser, M;
Eger, L;
Oelschlaegel, U;
Auffermann-Gretzinger, S;
Kiani, A;
Schetelig, J;
Illmer, T;
Schaich, M;
Corbeil, D;
Thiede, C;
Ehninger, G;
Bornhäuser, M

Publication type:

Letter

Single-agent thalidomide for treatment of first relapse following high-dose chemotherapy in patients with multiple myeloma.

Published in:

2005

By:

Fenk, R;
Hoyer, B;
Steidl, U;
Kondakci, M;
Graef, T;
Heuk, R;
Ruf, L;
Strupp, C;
Neumann, F;
Rohr, U-P;
Hildebrandt, B;
Haas, R;
Kobbe, G

Publication type:

Letter

A new translocation t(9;11)(q34;p15) fuses NUP98 to a novel homeobox partner gene, PRRX2, in a therapy-related acute myeloid leukemia.

Published in:

2005

By:

Gervais, C;
Mauvieux, L;
Perrusson, N;
Hélias, C;
Struski, S;
Leymarie, V;
Lioure, B;
Lessard, M

Publication type:

Letter

Efficacy and safety of rasburicase, a recombinant urate oxidase (Elitek), in the management of malignancy-associated hyperuricemia in pediatric and adult patients: final results of a multicenter compassionate use trial.

Published in:

2005

By:

Jeha, S;
Kantarjian, H;
Irwin, D;
Shen, V;
Shenoy, S;
Blaney, S;
Camitta, B;
Pui, C-H

Publication type:

journal article

Analysis of efficacy and toxicity of thalidomide in 122 patients with multiple myeloma: response of soft-tissue plasmacytomas.

Published in:

2005

By:

Wu, K L;
Helgason, H H;
van der Holt, B;
Wijermans, P W;
Lokhorst, H M;
Smit, W M;
Sonneveld, P

Publication type:

Letter

Allogeneic stem cell transplantation reverses the poor prognosis of CML patients with deletions in derivative chromosome 9.

Published in:

2005

By:

Lundán, T;
Volin, L;
Ruutu, T;
Knuutila, S;
Porkka, K

Publication type:

Letter

Checkpoint kinase 1 (CHK1) protein and mRNA expression is downregulated in aggressive variants of human lymphoid neoplasms.

Published in:

2005

By:

Tort, F;
Hernández, S;
Beà, S;
Camacho, E;
Fernández, V;
Esteller, M;
Fraga, M F;
Burek, C;
Rosenwald, A;
Hernández, L;
Campo, E;
Hernández, S;
Beà, S;
Fernández, V;
Hernández, L

Publication type:

journal article

Minor histocompatibility antigen-specific T cells with multiple distinct specificities can be isolated by direct cloning of IFN?-secreting T cells from patients with relapsed leukemia responding to donor lymphocyte infusion.

Published in:

Leukemia (08876924), 2005, v. 19, n. 1, p. 83, doi. 10.1038/sj.leu.2403572

By:

Kloosterboer, F M;
van Luxemburg-Heijs, S A P;
van Soest, R A;
van Egmond, H M;
Barbui, A M;
Strijbosch, M P W;
Willemze, R;
Falkenburg, J H F

Publication type:

Article

Equilibrative nucleoside transporter-2 (hENT2) protein expression correlates with ex vivo sensitivity to fludarabine in chronic lymphocytic leukemia (CLL) cells.

Published in:

Leukemia (08876924), 2005, v. 19, n. 1, p. 64, doi. 10.1038/sj.leu.2403582

By:

Molina-Arcas, M;
Marcé, S;
Villamor, N;
Huber-Ruano, I;
Casado, F J;
Bellosillo, B;
Montserrat, E;
Gil, J;
Colomer, D;
Pastor-Anglada, M

Publication type:

Article

Alemtuzumab in the treatment of relapsed acute lymphoid leukaemia.

Published in:

2005

By:

Piccaluga, P P;
Martinelli, G;
Malagola, M;
Rondoni, M;
Bonifazi, F;
Bandini, G;
Visani, G;
Baccarani, M

Publication type:

Letter

Reply to Piccaluga et al.

Published in:

2005

By:

Laporte, J-P;
Isnard, F;
Fouillard, L;
Garderet, L;
Gorin, N-C

Publication type:

Letter

Novel mutations in the FLT3 gene in adult patients with refractory acute myeloid leukemia.

Published in:

2005

By:

Choi, Y;
Kim, H-J;
Park, B-H;
Min, W-S;
Kim, C-C

Publication type:

Letter

Bedside RNA stabilizing kit systems for gene expression analysis of acute leukemias: influence of non-neoplastic white blood cells.

Published in:

2005

By:

Zebisch, A;
Linkesch, W;
Sill, H

Publication type:

Letter

A phase I study of153Sm-EDTMP with fixed high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma.

Published in:

Leukemia (08876924), 2005, v. 19, n. 1, p. 118, doi. 10.1038/sj.leu.2403575

By:

Dispenzieri, A;
Wiseman, G A;
Lacy, M Q;
Litzow, M R;
Anderson, P M;
Gastineau, D A;
Tefferi, A;
Inwards, D J;
Micallef, I N M;
Ansell, S M;
Porrata, L;
Elliott, M A;
Lust, J A;
Greipp, P R;
Rajkumar, S V;
Fonseca, R;
Witzig, T E;
Erlichman, C;
Sloan, J A;
Gertz, M A

Publication type:

Article

Hematopoietic stem-cell transplantation from unrelated donors in elderly patients (age>55 years) with hematologic malignancies: older age is no longer a contraindication when using reduced intensity conditioning.

Published in:

Leukemia (08876924), 2005, v. 19, n. 1, p. 7, doi. 10.1038/sj.leu.2403591

By:

Shimoni, A;
Kröger, N;
Zabelina, T;
Ayuk, F;
Hardan, I;
Yeshurun, M;
Shem-Tov, N;
Avigdor, A;
Ben-Bassat, I;
Zander, A R;
Nagler, A

Publication type:

Article

Unrelated donor transplantation over the age of 55. Are we merely getting (b)older?

Published in:

Leukemia (08876924), 2005, v. 19, n. 1, p. 31, doi. 10.1038/sj.leu.2403594

By:

van Besien, K;
Artz, A;
Stock, W

Publication type:

Article

Works matching IS 08876924 AND DT 2005 AND VI 19 AND IP 1

A phase I study of 153Sm-EDTMP with fixed high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma.

Evidence for D276G and L364I Bcr-Abl mutations in Ph+leukaemic cells obtained from patients resistant to Imatinib.

Raf and VEGF: emerging therapeutic targets in Kaposi's sarcoma-associated herpesvirus infection and angiogenesis in hematopoietic and nonhematopoietic tumors.

Raji revisited: cytogenetics of the original Burkitt's lymphoma cell line.

Translocation t(1;19) is related to low cellular drug resistance in childhood acute lymphoblastic leukaemia.

Efficacy of melphalan, arsenic trioxide, and ascorbic acid combination therapy (MAC) in relapsed and refractory multiple myeloma.

Multipotent neural precursors express neural and hematopoietic factors, and enhance ex vivo expansion of cord blood CD34<sup>+</sup> cells, colony forming units and NOD/SCID-repopulating cells in contact and noncontact cultures.

Translocation t(1;6)(p35.3;p25.2): a new recurrent aberration in‘unmutated’B-CLL.

Is physical fitness decreased in survivors of childhood leukemia? A systematic review.

KIAA1509 is a novel PDGFRB fusion partner in imatinib-responsive myeloproliferative disease associated with a t(5;14)(q33;q32).

Anagrelide is effective in treating patients with hydroxyurea-resistant thrombocytosis in patients with chronic myeloid leukemia.

CD34<sup>+</sup> marrow progenitors from MDS patients with high levels of intramedullary apoptosis have reduced expression ofa4ß1 anda5ß1 integrins.

Induction of gene expression by 5-Aza-2'-deoxycytidine in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) but not epithelial cells by DNA-methylation-dependent and -independent mechanisms.

Immunosurveillance of childhood ALL: polymorphic interferon-?alleles are associated with age at diagnosis and clinical risk groups.

Overexpression of HOXB4 confers a myelo-erythroid differentiation delay in vitro.

Phenotype and function of a CD56+peripheral blood monocyte.

Development of a D-FISH method to detect DEK/CAN fusion resulting from t(6;9)(p23;q34) in patients with acute myelogenous leukemia.

Impact of plasmacytoid dendritic cells on outcome after reduced-intensity conditioning allogeneic stem cell transplantation.

Drug-induced immunophenotypic modulation in childhood ALL: implications for minimal residual disease detection.

Inhibition of PI3K, mTOR and MEK signaling pathways promotes rapid apoptosis in B-lineage ALL in the presence of stromal cell support.

Immune recovery after low-dose Campath therapy in a group of pretreated patients affected by B-cell chronic lymphocytic leukemia.

Rapid reconstitution of dendritic cells after allogeneic transplantation of CD133+ selected hematopoietic stem cells.

Single-agent thalidomide for treatment of first relapse following high-dose chemotherapy in patients with multiple myeloma.

A new translocation t(9;11)(q34;p15) fuses NUP98 to a novel homeobox partner gene, PRRX2, in a therapy-related acute myeloid leukemia.

Efficacy and safety of rasburicase, a recombinant urate oxidase (Elitek), in the management of malignancy-associated hyperuricemia in pediatric and adult patients: final results of a multicenter compassionate use trial.

Analysis of efficacy and toxicity of thalidomide in 122 patients with multiple myeloma: response of soft-tissue plasmacytomas.

Allogeneic stem cell transplantation reverses the poor prognosis of CML patients with deletions in derivative chromosome 9.

Checkpoint kinase 1 (CHK1) protein and mRNA expression is downregulated in aggressive variants of human lymphoid neoplasms.

Minor histocompatibility antigen-specific T cells with multiple distinct specificities can be isolated by direct cloning of IFN?-secreting T cells from patients with relapsed leukemia responding to donor lymphocyte infusion.

Equilibrative nucleoside transporter-2 (hENT2) protein expression correlates with ex vivo sensitivity to fludarabine in chronic lymphocytic leukemia (CLL) cells.

Alemtuzumab in the treatment of relapsed acute lymphoid leukaemia.

Reply to Piccaluga et al.

Novel mutations in the FLT3 gene in adult patients with refractory acute myeloid leukemia.

Bedside RNA stabilizing kit systems for gene expression analysis of acute leukemias: influence of non-neoplastic white blood cells.

A phase I study of<sup>153</sup>Sm-EDTMP with fixed high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma.

Hematopoietic stem-cell transplantation from unrelated donors in elderly patients (age>55 years) with hematologic malignancies: older age is no longer a contraindication when using reduced intensity conditioning.

Unrelated donor transplantation over the age of 55. Are we merely getting (b)older?